Literature DB >> 20931278

QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine.

Eslam Pourbasheer1, Siavash Riahi, Mohammad Reza Ganjali, Parviz Norouzi.   

Abstract

Multiple linear regressions (MLR) and support vector machine (SVM) were used to develop quantitative structure-activity relationship (QSAR) models of novel Hepatitis C virus (HCV) NS5B polymerase inhibitors. Various kinds of molecular descriptors were calculated to represent the molecular structures of compounds, such as chemical, topological, geometrical, and quantum descriptors. Principal component analysis (PCA) was used to select the training set. A variable selection method utilizing a genetic algorithm (GA) was employed to select from the large pool of calculated descriptors, an optimal subset of descriptors which have significant contribution to the overall inhibitory activity. The models were validated using Leave-One-Out (LOO) and Leave-Group-Out (LGO) crossvalidation, and Y-randomization test. Results demonstrated the SVM model offers powerful prediction capabilities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20931278     DOI: 10.1007/s11030-010-9283-0

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  21 in total

1.  A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs.

Authors:  Antreas Afantitis; Georgia Melagraki; Haralambos Sarimveis; Panayiotis A Koutentis; Olga Igglessi-Markopoulou; George Kollias
Journal:  Mol Divers       Date:  2009-05-30       Impact factor: 2.943

2.  A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.

Authors:  Hongying Du; Jie Wang; Xiaoyun Zhang; Zhide Hu
Journal:  Eur J Med Chem       Date:  2008-02-29       Impact factor: 6.514

3.  QSAR prediction of toxicity of nitrobenzenes.

Authors:  V K Agrawal; P V Khadikar
Journal:  Bioorg Med Chem       Date:  2001-11       Impact factor: 3.641

4.  Investigation of different linear and nonlinear chemometric methods for modeling of retention index of essential oil components: concerns to support vector machine.

Authors:  Siavash Riahi; Eslam Pourbasheer; Mohammad Reza Ganjali; Parviz Norouzi
Journal:  J Hazard Mater       Date:  2008-12-03       Impact factor: 10.588

5.  QSAR study on melanocortin-4 receptors by support vector machine.

Authors:  Eslam Pourbasheer; Siavash Riahi; Mohammad Reza Ganjali; Parviz Norouzi
Journal:  Eur J Med Chem       Date:  2009-12-23       Impact factor: 6.514

6.  Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.

Authors:  Yuefen Zhou; Stephen E Webber; Douglas E Murphy; Lian-Sheng Li; Peter S Dragovich; Chinh V Tran; Zhongxiang Sun; Frank Ruebsam; Amit M Shah; Mei Tsan; Richard E Showalter; Rupal Patel; Bin Li; Qiang Zhao; Qing Han; Thomas Hermann; Charles R Kissinger; Laurie Lebrun; Maria V Sergeeva; Leo Kirkovsky
Journal:  Bioorg Med Chem Lett       Date:  2008-01-08       Impact factor: 2.823

7.  3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.

Authors:  Pallav D Patel; Maulik R Patel; Neerja Kaushik-Basu; Tanaji T Talele
Journal:  J Chem Inf Model       Date:  2007-12-13       Impact factor: 4.956

8.  Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site.

Authors:  Ariamala Gopalsamy; Rajiv Chopra; Kitae Lim; Gregory Ciszewski; Mengxiao Shi; Kevin J Curran; Steven F Sukits; Kristine Svenson; Joel Bard; John W Ellingboe; Atul Agarwal; Girija Krishnamurthy; Anita Y M Howe; Mark Orlowski; Boris Feld; John O'Connell; Tarek S Mansour
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

9.  Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties.

Authors:  Maria V Sergeeva; Yuefen Zhou; Darian M Bartkowski; Thomas G Nolan; Daniel A Norris; Ellen Okamoto; Leo Kirkovsky; Ruhi Kamran; Laurie A Lebrun; Mei Tsan; Rupal Patel; Amit M Shah; Matthew Lardy; Alberto Gobbi; Lian-Sheng Li; Jingjing Zhao; Thomas Bertolini; Nebojsa Stankovic; Zhongxiang Sun; Douglas E Murphy; Stephen E Webber; Peter S Dragovich
Journal:  Bioorg Med Chem Lett       Date:  2008-04-04       Impact factor: 2.823

10.  Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.

Authors:  Peter S Dragovich; Julie K Blazel; David A Ellis; Qing Han; Ruhi Kamran; Charles R Kissinger; Laurie A LeBrun; Lian-Sheng Li; Douglas E Murphy; Michael Noble; Rupal A Patel; Frank Ruebsam; Maria V Sergeeva; Amit M Shah; Richard E Showalter; Chinh V Tran; Mei Tsan; Stephen E Webber; Leo Kirkovsky; Yuefen Zhou
Journal:  Bioorg Med Chem Lett       Date:  2008-08-29       Impact factor: 2.823

View more
  4 in total

1.  Large-scale structure-activity relationship study of hepatitis C virus NS5B polymerase inhibition using SMILES-based descriptors.

Authors:  Apilak Worachartcheewan; Virapong Prachayasittikul; Alla P Toropova; Andrey A Toropov; Chanin Nantasenamat
Journal:  Mol Divers       Date:  2015-11       Impact factor: 2.943

2.  QSAR Study of 17β-HSD3 Inhibitors by Genetic Algorithm-Support Vector Machine as a Target Receptor for the Treatment of Prostate Cancer.

Authors:  Eslam Pourbasheer; Saadat Vahdani; Davood Malekzadeh; Reza Aalizadeh; Amin Ebadi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

3.  HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors.

Authors:  Abid Qureshi; Akanksha Rajput; Gazaldeep Kaur; Manoj Kumar
Journal:  J Cheminform       Date:  2018-03-09       Impact factor: 5.514

4.  Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.

Authors:  Yu Wei; Jinlong Li; Jie Qing; Mingjie Huang; Ming Wu; Fenghua Gao; Dongmei Li; Zhangyong Hong; Lingbao Kong; Weiqiang Huang; Jianping Lin
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.